EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada

Mohit Bhutani, Alan Kaplan, Sheena Kayaniyil, Kyla Jamieson, Ross Ormsby, John Bell, Prachi Bhatt, Jennifer Carioto, Bruce Pyenson

Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation · 2026 · 13 (3) · 184-194

DOI: 10.15326/jcopdf.2025.0687 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 2026. Verfasst von Mohit Bhutani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: AstraZeneca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

COPDpopulation modelsingle-inhaler triple therapy

Autor:innen und Institutionen

  • Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
  • Family Physician Airways Group of Canada, and University of Toronto, Toronto, Ontario, Canada
  • Scientific Affairs, AstraZeneca, Mississauga, Canada
  • BioPharmaceuticals Medical, AstraZeneca, Cambridge, United Kingdom
  • Milliman, New York, New York, United States

Förderung

  • AstraZeneca

Zitieren

APA

Bhutani, M., Kaplan, A., Kayaniyil, S., Jamieson, K., Ormsby, R., Bell, J., Bhatt, P., Carioto, J., & Pyenson, B. (2026). Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 13(3), 184-194. https://doi.org/10.15326/jcopdf.2025.0687

Vancouver

Bhutani M, Kaplan A, Kayaniyil S, Jamieson K, Ormsby R, Bell J, et al. Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation. 2026;13(3):184-194. doi:10.15326/jcopdf.2025.0687

BibTeX
@article{Bhutani2026,
  author = {Bhutani, Mohit and Kaplan, Alan and Kayaniyil, Sheena and Jamieson, Kyla and Ormsby, Ross and Bell, John and Bhatt, Prachi and Carioto, Jennifer and Pyenson, Bruce},
  title = {Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada},
  journal = {Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation},
  year = {2026},
  volume = {13},
  number = {3},
  pages = {184--194},
  doi = {10.15326/jcopdf.2025.0687}
}
Kostenlos starten →